Judge Finds Warner-Lambert Accupril Patent Enabled
A federal judge has ruled that claims of the patent involved in a long-standing dispute between Warner-Lambert Co. and generic maker Teva Pharmaceuticals USA Inc. are enabled, rejecting Teva's theory of...To view the full article, register now.
Already a subscriber? Click here to view full article